Deep-Learning and HPC to Boost Biomedical Applications for Health

Type of project: European  |  Start date: 01/01/2019  |  End date: 30/06/2022

Health scientific discovery and innovation are expected to quickly move forward under the so called “fourth paradigm of science”, which relies on unifying the traditionally separated and heterogeneous high-performance computing and big data analytics environments.
Under this paradigm, the DeepHealth project will provide HPC computing power at the service of biomedical applications and apply Deep Learning (DL) techniques on large and complex biomedical datasets to support new and more efficient ways of diagnosis, monitoring and treatment of diseases.
DeepHealth will develop a flexible and scalable framework for the HPC + Big Data environment, based on two new libraries: the European Distributed Deep Learning Library (EDDLL) and the European Computer Vision Library (ECVL).
The framework will be validated in 14 use cases which will allow to train models and provide training data from different medical areas (migraine, dementia, depression etc.).
The resulting trained models and the libraries will be integrated and validated in 7 existing biomedical software platforms, which include: a) commercial platforms (e.g. PHILIPS Clinical Decision Support System or THALES SIX PIAF); b) research oriented platforms (e.g. CEA’s ExpressIF™ or CRS4’s Digital Pathology).
Impact is measured by tracking the time-to-model-in-production (ttmip).
Through this approach, DeepHealth will also standardize HPC resources to the needs of DL applications and underpin the compatibility and uniformity on the set of tools used by medical staff and expert users.
The final DeepHealth solution will be compatible with HPC infrastructures ranging from the ones in supercomputing centers to the ones in hospitals.
DeepHealth involves 21 partners from 9 European countries, gathering a multidisciplinary group from research organisations (9), health organisations (4) as well as (4) large and (4) small and medium industrial partners, with a strong commitment towards innovation, exploitation and sustainability.
Due to the COVID-19 pandemic, the project has obtained a 6-months extension (from 31/12/2021 to 30/06/2022).


Funding programme:
Horizon 2020

Funding body:
European Commission

Grant agreement:


CNR-ILC role:
Third Party

Franco Alberto Cardillo
Noemi Terreni